Yolanda Bravo Vergel

Summary

Affiliation: University of York
Country: UK

Publications

  1. ncbi The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Y Bravo Vergel
    Centre for Health Economics, University of York, Heslington, YO10 5DD York, UK
    Rheumatology (Oxford) 46:1729-35. 2007
  2. ncbi Difficult commissioning choices: lessons from English primary care trusts
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    J Health Serv Res Policy 11:150-4. 2006
  3. ncbi Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    N Woolacott
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 10:iii-iv, xiii-xvi, 1-239. 2006
  4. ncbi A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder
    K Soares Weiser
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 11:iii-iv, ix-206. 2007
  5. ncbi Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    Heart 93:1238-43. 2007
  6. ncbi Making decisions under uncertainty--the role of probabilistic decision modelling
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Fam Pract 23:391-2. 2006

Collaborators

Detail Information

Publications6

  1. ncbi The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
    Y Bravo Vergel
    Centre for Health Economics, University of York, Heslington, YO10 5DD York, UK
    Rheumatology (Oxford) 46:1729-35. 2007
    ..We assess the cost-effectiveness of two TNF antagonists and so-called 'palliative care' for the treatment of active PsA from the perspective of the UK National Health Service (NHS)...
  2. ncbi Difficult commissioning choices: lessons from English primary care trusts
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    J Health Serv Res Policy 11:150-4. 2006
    ..Our objective was to describe recent local developments on prioritization decision-making...
  3. ncbi Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
    N Woolacott
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 10:iii-iv, xiii-xvi, 1-239. 2006
    ..Further research should include long-term controlled trials to confirm benefits, review adverse events and to explore further the implications of biologic therapy...
  4. ncbi A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder
    K Soares Weiser
    Centre for Reviews and Dissemination, University of York, UK
    Health Technol Assess 11:iii-iv, ix-206. 2007
    ..To determine the clinical effectiveness and cost-effectiveness of pharmacological and/or psychosocial interventions for the prevention of relapse in people with bipolar disorder...
  5. ncbi Is primary angioplasty cost effective in the UK? Results of a comprehensive decision analysis
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York, UK
    Heart 93:1238-43. 2007
    ..To assess the cost effectiveness of primary angioplasty, compared with medical management with thrombolytic drugs, to achieve reperfusion after acute myocardial infarction (AMI) from the perspective of the UK NHS...
  6. ncbi Making decisions under uncertainty--the role of probabilistic decision modelling
    Yolanda Bravo Vergel
    Centre for Health Economics, University of York, York YO10 5DD, UK
    Fam Pract 23:391-2. 2006